rethinkPeptides Search
Menu
Study breakdown

Blood Pressure-Lowering Peptides Identified from Lupin Protein Using Ultrasound and Computer Modeling

evidence
The takeaway

Ultrasound-treated lupin protein hydrolysates showed ACE-inhibitory activity, and computational modeling identified six novel peptides as potential natural blood pressure-lowering compounds.

6 novel ACE-inhibitory peptides

Molecular docking predicted six unique peptide sequences from lupin protein hydrolysates as potential natural blood pressure-lowering compounds.

What the researchers found

Lupin protein treated with ultrasound and then enzymatically hydrolyzed produced peptide mixtures with ACE-inhibitory activity. The unfractionated alcalase hydrolysate (IC50 = 3.21 mg/mL) and flavourzyme hydrolysate (IC50 = 3.32 mg/mL) were more potent than their ultrafiltrated fractions (IC50 = 6.09–7.45 mg/mL), suggesting synergistic effects among peptides.

Molecular docking analysis identified six novel peptides as predicted ACE inhibitors: AIPPGIPY, SVPGCT, and QGAGG from the alcalase hydrolysate, and AIPINNPGKL, SGNQGP, and PPGIP from the flavourzyme hydrolysate.

Why it matters

High blood pressure affects over a billion people worldwide, and there is growing interest in food-derived bioactive peptides as natural alternatives or supplements to pharmaceutical ACE inhibitors. Identifying specific peptide sequences from lupin protein could lead to functional foods or nutraceuticals for blood pressure management, adding value to an underutilized plant protein source.

How the study worked

Lupin protein isolate was pre-treated with ultrasound and then hydrolyzed using two different enzymes (alcalase and flavourzyme). The resulting hydrolysates were fractionated by molecular weight (1, 5, and 10 kDa) using membrane ultrafiltration. ACE-inhibitory activity was measured in vitro. Molecular docking simulations were used to predict which specific peptide sequences in the hydrolysates were most likely responsible for ACE inhibition.

What this study cannot tell us

This study was entirely in vitro and computational — no animal or human testing was performed. Molecular docking predicts binding potential but does not confirm biological activity. The identified peptides have not been synthesized and tested individually. Whether these peptides survive digestion and reach the bloodstream in active form is unknown. The IC50 values are relatively high compared to pharmaceutical ACE inhibitors.

How to read the evidence

This is an in vitro and in-silico study with no animal or human data. The ACE inhibition was demonstrated in lab assays and the peptide candidates were predicted computationally. This represents early-stage discovery research.

When this study was published

Published in 2023, this is recent research in the active field of food-derived bioactive peptides. The identified peptides would need substantial further validation before any practical application.

The bigger picture

Food-derived bioactive peptides are an expanding area of research linking nutrition and health. This study adds lupin to the growing list of plant proteins that yield ACE-inhibitory peptides, alongside well-studied sources like milk, soy, and fish. The use of ultrasound pre-treatment represents an emerging approach to enhancing bioactive peptide release from plant proteins.

Questions still open

  • Would these lupin-derived peptides survive gastrointestinal digestion and remain active as ACE inhibitors in the body?
  • How do these peptide IC50 values compare to established food-derived ACE inhibitors like those from milk casein?
  • Could ultrasound pre-treatment be applied to other plant proteins to enhance release of bioactive peptides?

Common questions

Can eating lupin lower blood pressure?
This study identified peptides in lupin protein that can block ACE (a blood pressure-raising enzyme) in lab tests, but these results haven't been confirmed in humans. Whether eating lupin or lupin-based supplements could meaningfully lower blood pressure remains to be studied.
What role does ultrasound play in releasing bioactive peptides from food proteins?
Ultrasound pre-treatment helps unfold and break apart protein structures before enzyme digestion, making it easier to release small bioactive peptides. In this study, ultrasound-treated lupin protein yielded hydrolysates with ACE-inhibitory activity and six novel peptide candidates.

Read the original research

Novel antihypertensive peptides from lupin protein hydrolysate: An in-silico identification and molecular docking studies.

Food chemistry, 407, 135082

Citation

Fadimu, Gbemisola J; Gan, Chee-Yuen; Olalere, Olusegun A; Farahnaky, Asgar; Gill, Harsharn; Truong, Tuyen. (2023). Novel antihypertensive peptides from lupin protein hydrolysate: An in-silico identification and molecular docking studies.. Food chemistry, 407, 135082. https://doi.org/10.1016/j.foodchem.2022.135082